543904:BOM
Mankind Pharma Ltd
₹2,354.80
arrow_upward
+1.06%(+24.70) 1D
Oct 15, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 543904...
Open
₹2,376.75
High
₹2,376.75
Low
₹2,323.00
Mkt. cap
970.28B
Avg. vol.
41.38K
Volume
20.00K
P/E ratio
47.65
52-wk high
₹2,640.30
52-wk low
₹1,909.90
EPS
₹49.42
No. of employees
20K
Open
₹2,376.75
High
₹2,376.75
Low
₹2,323.00
Mkt. cap
970.28B
Avg. vol.
41.38K
Volume
20.00K
P/E ratio
47.65
52-wk high
₹2,640.30
52-wk low
₹1,909.90
EPS
₹49.42
No. of employees
20K
News stories
From web sources and news partners
Quartz
·
20 minutes ago
S&P 500 and Nasdaq fall as tech drops for a second day and wholesale inflation jumps
Forbes
·
48 minutes ago
Why Stocks Are Getting Cheaper Even As The S&P 500 Hits Record Highs
富途牛牛
·
54 minutes ago
"Super Bull" Yardeni Lowers S&P Year-End Target: Earnings Are Not the Issue, Valuation Is
Yahoo Finance
·
3 hours ago
SPDR Portfolio S&P 500 Value ETF (SPYV) Adds Apple and Amazon on Oct. 13
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees20.5K
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitemankindpharma.com